These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 21099444
1. Effectiveness of haemophilus influenzae type B conjugate vaccine for prevention of meningitis in Senegal. Fleming JA, Dieye Y, Ba O, Mutombo wa Mutombo B, Diallo N, Faye PC, Ba M, Cisse MF, Diallo AG, Ba M, Slack MP, Weiss NS. Pediatr Infect Dis J; 2011 May; 30(5):430-2. PubMed ID: 21099444 [Abstract] [Full Text] [Related]
3. Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda. Muganga N, Uwimana J, Fidele N, Gahimbare L, Gessner BD, Mueller JE, Mhlanga BR, Katsande R, Herbinger KH, Rugambwa C. Vaccine; 2007 Sep 28; 25(39-40):7001-5. PubMed ID: 17709159 [Abstract] [Full Text] [Related]
4. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study. Lee EH, Lewis RF, Makumbi I, Kekitiinwa A, Ediamu TD, Bazibu M, Braka F, Flannery B, Zuber PL, Feikin DR. Trop Med Int Health; 2008 Apr 28; 13(4):495-502. PubMed ID: 18312475 [Abstract] [Full Text] [Related]
5. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Ribeiro GS, Lima JB, Reis JN, Gouveia EL, Cordeiro SM, Lobo TS, Pinheiro RM, Ribeiro CT, Neves AB, Salgado K, Silva HR, Reis MG, Ko AI. Vaccine; 2007 May 30; 25(22):4420-8. PubMed ID: 17449150 [Abstract] [Full Text] [Related]
6. Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years. Renner LA, Newman MJ, Ahadzie L, Antwi-Agyei KO, Eshetu M. Pediatr Infect Dis J; 2007 Apr 30; 26(4):356-8. PubMed ID: 17414404 [Abstract] [Full Text] [Related]
8. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia. Gessner BD, Sedyaningsih ER, Griffiths UK, Sutanto A, Linehan M, Mercer D, Mulholland EK, Walker DG, Steinhoff M, Nadjib M. Pediatr Infect Dis J; 2008 May 30; 27(5):438-43. PubMed ID: 18398383 [Abstract] [Full Text] [Related]
9. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries. Garcia S, Lagos R, Muñoz A, Picón T, Rosa R, Alfonso A, Abriata G, Gentile A, Romanin V, Regueira M, Chiavetta L, Agudelo CI, Castañeda E, De la Hoz F, Higuera AB, Arce P, Cohen AL, Verani J, Zuber P, Gabastou JM, Pastor D, Flannery B, Andrus J. Vaccine; 2012 Jan 05; 30(2):486-92. PubMed ID: 22085550 [Abstract] [Full Text] [Related]
16. Positive effect of the introduction of Haemophilus influenzae type b vaccination in the expanded program on immunization in Cameroon. Massenet D, Tapindjin-Gake M. Vaccine; 2010 Sep 07; 28(39):6404-5. PubMed ID: 20674879 [Abstract] [Full Text] [Related]
17. Efficacy and Prolonged Safety of Haemophilus influenzae Type b Conjugate Vaccines. Tripathi N, Mukherjee S. Infect Disord Drug Targets; 2024 Sep 07; 24(5):e150124225640. PubMed ID: 38231056 [Abstract] [Full Text] [Related]
19. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines. Eskola J. J Intern Med; 2010 Mar 07; 267(3):241-50. PubMed ID: 20201918 [Abstract] [Full Text] [Related]